Company Filing History:
Years Active: 2023
Title: John F Ackermann: Innovator in Adaptive Clinical Assessment Scheduling
Introduction
John F Ackermann is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of clinical assessments through his innovative patent. His work focuses on enhancing the efficiency and accuracy of data collection in clinical settings.
Latest Patents
John F Ackermann holds a patent for a "Method and system for adaptive scheduling of clinical assessments." This invention provides methods and systems that allow for adaptive assessment of a physical subject. It efficiently collects assessment data and modifies an assessment schedule based on analyses. The system controls the timing of each assessment to gather data at the most informative times and conditions. This adaptive approach minimizes the frequency of data collection without sacrificing accuracy or precision. It also increases test reliability by reducing redundancy. The ability to estimate an unknown underlying function with a small number of constant free parameters significantly reduces the error of the function estimate. This innovation enhances the statistical power of clinical trials by achieving accurate estimates of measurement error with minimal sampled assessments.
Career Highlights
Throughout his career, John F Ackermann has worked with esteemed institutions such as Northeastern University and The Schepens Eye Research Institute, Inc. His experience in these organizations has contributed to his expertise in clinical assessments and adaptive scheduling.
Collaborations
John has collaborated with notable colleagues, including Peter Bex and Tobias Elze. Their combined efforts have further advanced the field of clinical assessment methodologies.
Conclusion
John F Ackermann's innovative work in adaptive clinical assessment scheduling has the potential to transform data collection in clinical trials. His contributions are significant in enhancing the reliability and efficiency of assessments.